352
- Minutolo R, Agarwal R, Borrelli S, Chiodini P, Bellizzi V, Nappi F, et al. Prognostic role of
ambulatory blood pressure measurement in patients with nondialysis chronic kidney disease.
Arch Intern Med. 2011;171(12):1090–8. - National Institute for Health and Clinical Excellence. Hypertension: clinical management of
hypertension in adults [clinical guideline 127]. London: NICE; 2011. - O’Brien E, Parati G, Stergiou G, Asmar R, Beilin L, Bilo G, et al. European Society of
Hypertension position paper on ambulatory blood pressure monitoring. J Hypertens.
2013;31(9):1731–68. - Muxfeldt ES, Barros GS, Viegas BB, Carlos FO, Salles GF. Is home blood pressure moni-
toring useful in the management of patients with resistant hypertension? Am J Hypertens.
2015;28(2):190–9. - Nasothimiou EG, Tzamouranis D, Roussias LG, Stergiou GS. Home versus ambulatory blood
pressure monitoring in the diagnosis of clinic resistant and true resistant hypertension. J Hum
Hypertens. 2012;26(12):696–700. - Ruiz-Hurtado G, Gorostidi M, Waeber B, Ruilope LM. Ambulatory and home blood pressure
monitoring in people with chronic kidney disease. Time to abandon clinic blood pressure mea-
surements? Curr Opin Nephrol Hypertens. 2015;24(6):488–91. - Yakovlevitch M, Black HR. Resistant hypertension in a tertiary care clinic. Arch Intern Med.
1991;151(9):1786–92. - Jung O, Gechter JL, Wunder C, Paulke A, Bartel C, Geiger H, et al. Resistant hypertension?
Assessment of adherence by toxicological urine analysis. J Hypertens. 2013;31(4):766–74. - Pimenta E, Gaddam KK, Oparil S, Aban I, Husain S, Dell'Italia LJ, et al. Effects of dietary
sodium reduction on blood pressure in subjects with resistant hypertension: results from a
randomized trial. Hypertension. 2009;54(3):475–81. - Kanbay M, Chen Y, Solak Y, Sanders PW. Mechanisms and consequences of salt sensitivity
and dietary salt intake. Curr Opin Nephrol Hypertens. 2011;20(1):37–43. - Kaplan NM. Resistant hypertension. J Hypertens. 2005;23(8):1441–4.
- Modolo R, de Faria AP, Sabbatini AR, Barbaro NR, Ritter AM, Moreno H. Refractory and
resistant hypertension: characteristics and differences observed in a specialized clinic. J Am
Soc Hypertens. 2015;9(5):397–402. - Lloyd-Jones DM, Evans JC, Larson MG, O'Donnell CJ, Roccella EJ, Levy D. Differential
control of systolic and diastolic blood pressure: factors associated with lack of blood pressure
control in the community. Hypertension. 2000;36(4):594–9. - Abuyassin B, Sharma K, Ayas NT, Laher I. Obstructive sleep apnea and kidney disease: a
potential bidirectional relationship? J Clin Sleep Med. 2015;11(8):915–24. - Iseki K, Tohyama K, Matsumoto T, Nakamura H. High prevalence of chronic kidney dis-
ease among patients with sleep related breathing disorder (SRBD). Hypertens Res.
2008;31(2):249–55. - Hyman DJ, Pavlik VN. Self-reported hypertension treatment practices among primary care
physicians: blood pressure thresholds, drug choices, and the role of guidelines and evidence-
based medicine. Arch Intern Med. 2000;160(15):2281–6. - Agarwal R, Sinha AD. Thiazide diuretics in advanced chronic kidney disease. J Am Soc
Hypertens. 2012;6(5):299–308. - Dussol B, Moussi-Frances J, Morange S, Somma-Delpero C, Mundler O, Berland Y. A pilot
study comparing furosemide and hydrochlorothiazide in patients with hypertension and stage
4 or 5 chronic kidney disease. J Clin Hypertens (Greenwich). 2012;14(1):32–7. - Judd E, Calhoun DA. Management of hypertension in CKD: beyond the guidelines. Adv
Chronic Kidney Dis. 2015;22(2):116–22. - Chapman N, Dobson J, Wilson S, Dahlof B, Sever PS, Wedel H, et al. Effect of spironolactone
on blood pressure in subjects with resistant hypertension. Hypertension. 2007;49(4):839–45. - Rossi GP, Bernini G, Caliumi C, Desideri G, Fabris B, Ferri C, et al. A prospective study of
the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol.
2006;48(11):2293–300.
Y. S o l a k